Wu G.; Pea F.; Cossettini P.; Furlanut M., Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance, «JOURNAL OF PHARMACY AND PHARMACOLOGY», 1998, 50, pp. 343 - 349 [articolo]
Benetello P.; Furlanut M.; Fortunato M.; Pea F.; Baraldo M., Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association, «PHARMACOLOGICAL RESEARCH», 1997, 35, pp. 313 - 315 [articolo]
Benetello P.; Furlanut M.; Fortunato M.; Baraldo M.; Pea F.; Tognon A.; Testa G., Oral gabapentin disposition in patients with epilepsy after a high- protein meal, «EPILEPSIA», 1997, 38, pp. 1140 - 1142 [articolo]
Furlanut M.; Baraldo M.; Pea F.; Marzocchi V.; Croattino L.; Galla F., Blood concentrations and clinical effect of cyclosporin in psoriasis, «THERAPEUTIC DRUG MONITORING», 1996, 18, pp. 544 - 548 [articolo]
Furlanut M.; Baraldo M.; Galla F.; Marzocchi V.; Pea F., Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis, «PHARMACOLOGICAL RESEARCH», 1996, 33, pp. 349 - 352 [articolo]
Wu G.; Baraldo M.; Pea F.; Cossettini P.; Furlanut M., Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by bayesian and non-linear least squares methods, «PHARMACOLOGICAL RESEARCH», 1995, 32, pp. 355 - 362 [articolo]
DAMIANI, D; MICHIELI, M; MICHELUTTI, A; PEA, F; BARALDO, M; FANIN, R; RUSSO, D; FURLANUT, M; BACCARANI, M, P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases, «LEUKEMIA», 1995, 9, pp. 1792 - 1795 [replica/breve intervento]
Furlanut, M; Baraldo, M; Pea, F; Albanese, M C; Albertini, A; Puricelli, C, Effect of fluctuations of blood cyclosporine concentrations on renal function, «TRANSPLANTATION PROCEEDINGS», 1994, 26, pp. 2574 - 2575 [articolo]
Pea F.; Miglioli P.A.; Mazzo M.; Berti T., Study on the bactericidal activity and synergistic effect of neutropenic rat serum with gentamicin, «JOURNAL OF CHEMOTHERAPY», 1994, 6, pp. 117 - 120 [articolo]
Benedetti L.; Cortivo R.; Berti T.; Berti A.; Pea F.; Mazzo M.; Moras M.; Abatangelo G., Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats, «BIOMATERIALS», 1993, 14, pp. 1154 - 1160 [articolo]
Miglioli P.A.; Pea F.; Mazzo M.; Berti T., Comparison of the antibacterial activity and synergistic activity towards antibiotics of different mammalian sera, «JOURNAL OF CHEMOTHERAPY», 1993, 5, pp. 10 - 13 [articolo]
MIGLIOLI, PA; PEA, F; MAZZO, M; BERTI, T; LANZAFAME, P, POSSIBLE INFLUENCE OF ASSAY-METHODS IN STUDIES OF THE PHARMACOKINETICS OF ANTIBIOTICS, «JOURNAL OF CHEMOTHERAPY», 1993, 5, pp. 27 - 31 [articolo]
Miglioli P.A.; Pea F.; Mazzo M.; Berti T.; Casiglia E.; Pessina A.; Moretti V.; De Pascale A.; Palatini P., A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers, «DRUG INVESTIGATION», 1992, 4, pp. 391 - 394 [articolo]
D'Ancona S.; Mazzo M.; Pea F., Increased spontaneous cell detachment of F10 cells induced in vitro by some calcium-channel blockers, «JOURNAL OF CHEMOTHERAPY», 1992, 4, pp. 235 - 238 [articolo]
Pea F.; Mazzo M.; Miglioli P.A.; Casiglia E.; Pessina A.; Moretti V., Serum concentrations of sodium 2-mercaptoethanesulfonate (MESNA) and its metabolite, disulfide form (DIMESNA), in volunteers after oral dosing: A comparison between mesna and argimesna, «PHARMACOLOGICAL RESEARCH», 1992, 25, pp. 85 - 86 [articolo]
